This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Cannabis-Rx Announces $30 Million Financing

Cannabis-Rx (OTCQB:CANA), a company focused on funding the growth of the cannabis industry in states where it is licensed or permitted for medicinal and/or recreational purposes, today announced it will provide financing, commercial real estate solutions and consulting services to state licensed cannabis-related businesses. The company is not engaged in the growing, harvesting, cultivation, possession, or distribution of cannabis.

Cannabis-Rx, which has raised $30 million in capital, plans to invest in light industrial and commercial properties suited for the needs of dispensaries, medical clinics, growers, and those who may supply products and services to the cannabis industry. It will also consider additional investment opportunities in the licensed cannabis industry, ranging from retail and construction to nutrient lines and logistics, as well as providing start-up or operating capital to businesses that meet specific criteria in states where such activity is licensed and/or permissible.

“A number of factors have led to the rapid growth of the licensed cannabis industry, creating a significant need for new capital, infrastructure and resources to help it thrive,” said Llorn Kylo, chief executive officer of Cannabis-Rx. “We are uniquely positioned to capitalize on this opportunity by serving as a one-stop shop for licensed cannabis-related businesses seeking funding, real estate and guidance to help enhance operations and grow their enterprise.”

Cannabis-Rx is currently evaluating and/or pursing investment opportunities in Colorado, Washington and in states that permit the use and/or cultivation of medicinal marijuana. To complement its real estate and financing solutions, Cannabis-Rx plans to offer consulting services to licensed growers and operators.

Mr. Kylo is an experienced real estate executive, investor and developer. From 2002 to 2009 he owned and served as the Chief Executive Officer of Form 1 Land, Inc., a real estate development company. Shortly after, he formed Kylo Homes, a developer and manager of residential properties.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs